Association Between Pre-op Non-Selective Beta-Blockers and Hepatocellular Carcinoma Recurrence Post-Liver Transplant
Conditions: Hepatocellular Carcinoma Recurrent; Hepatocellular Carcinoma Interventions: Drug: Non-Selective Beta-Adrenoreceptor Agonists for Systemic Use Sponsors: Asan Medical Center; Korea Health Industry Development Institute Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Beta-Blockers | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Transplant | Research | Transplant Surgery | Transplants | Urology & Nephrology